In last trading session, Teladoc Health Inc (NYSE:TDOC) saw 7.14 million shares changing hands with its beta currently measuring 1.67. Company’s recent per share price level of $8.88 trading at -$0.12 or -1.33% at ring of the bell on the day assigns it a market valuation of $1.54B. That closing price of TDOC’s stock is at a discount of -76.58% from its 52-week high price of $15.68 and is indicating a premium of 23.87% from its 52-week low price of $6.76. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 9.45 million shares which gives us an average trading volume of 7.43 million if we extend that period to 3-months.
For Teladoc Health Inc (TDOC), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.50. Splitting up the data highlights that, out of 19 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 10 suggested the stock as a Hold whereas 9 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.36 in the current quarter.
Teladoc Health Inc (NYSE:TDOC) trade information
Upright in the red during last session for losing -1.33%, in the last five days TDOC remained trading in the red while hitting it’s week-highest on Thursday, 03/06/25 when the stock touched $8.88 price level, adding 10.3% to its value on the day. Teladoc Health Inc’s shares saw a change of -2.31% in year-to-date performance and have moved -1.66% in past 5-day. Teladoc Health Inc (NYSE:TDOC) showed a performance of -35.93% in past 30-days. Number of shares sold short was 25.02 million shares which calculate 2.22 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 11 to the stock, which implies a rise of 19.27% to its current value. Analysts have been projecting 9 as a low price target for the stock while placing it at a high target of 13. It follows that stock’s current price would drop -1.35% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1.35% for stock’s current value.
Teladoc Health Inc (TDOC) estimates and forecasts
This year revenue growth is estimated to fall -1.94% from the last financial year’s standing.
22 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 619.38M for the same. And 22 analysts are in estimates of company making revenue of 624.93M in the next quarter. Company posted 646.13M and 642.44M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -33.66% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 83.76% while estimates for its earnings growth in next 5 years are of 48.98%.
Teladoc Health Inc (NYSE:TDOC)’s Major holders
Insiders are in possession of 0.81% of company’s total shares while institution are holding 76.39 percent of that, with stock having share float percentage of 77.02%. Investors also watch the number of corporate investors in a company very closely, which is 76.39% institutions for Teladoc Health Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at TDOC for having 21.61 million shares of worth $211.35 million. And as of 2024-06-30, it was holding 12.8843 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 17.22 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.2643 of outstanding shares, having a total worth of $168.38 million.
